Clinical Trial Update: Pimavanserin for Insomnia in Veterans With PTSD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pimavanserin for insomnia in veterans with post-traumatic stress disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Post-traumatic Stress Disorder

Drugs mentioned

• Nuplazid (Pimavanserin)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Post-traumatic Stress Disorder, Insomnia | Phase 2 | Status: RECRUITING